A molecular understanding of D-homoestrone-induced G2/M cell cycle arrest in HeLa human cervical carcinoma cells.

作者: Renáta Minorics , Noémi Bózsity , Judit Molnár , János Wölfling , Erzsébet Mernyák

DOI: 10.1111/JCMM.12587

关键词:

摘要: 2-Methoxyestradiol (ME), one of the most widely investigated A-ring-modified metabolites estrone, exerts significant anticancer activity on numerous cancer cell lines. Its pharmacological actions, including cycle arrest, microtubule disruption and pro-apoptotic activity, have already been described in detail. The currently tested d-ring-modified analogue d-homoestrone, selectively inhibits cervical proliferation induces a G2/M phase blockade, resulting development apoptosis. question arose whether difference chemical structures these analogues can influence mechanism action. aim present study was therefore to elucidate molecular contributors intracellular processes induced by d-homoestrone HeLa cells. Apoptosis triggered develops through activation intrinsic pathway, as demonstrated determination activities caspase-8 -9. It revealed that d-homoestrone-treated cells are not able enter mitosis because cyclin-dependent kinase 1-cyclin B complex loses its decreased inactivation stathmin concomitant disturbance formation. However, unlike 2-ME, does exert direct effect tubulin polymerization. These results led conclusion d-homoestrone-triggered arrest apoptosis differ from those case 2-ME. This may be regarded an alternative action among steroidal compounds.

参考文章(42)
Nicola J. Mabjeesh, Daniel Escuin, Theresa M. LaVallee, Victor S. Pribluda, Glenn M. Swartz, Michelle S. Johnson, Margaret T. Willard, Hua Zhong, Jonathan W. Simons, Paraskevi Giannakakou, 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell. ,vol. 3, pp. 363- 375 ,(2003) , 10.1016/S1535-6108(03)00077-1
Chul-Hoon Lee, Haeyoung Lim, Sangik Moon, Choonshik Shin, Seunghyun Kim, Bum-Joon Kim, Yoongho Lim, Novel anticancer agent, benzyldihydroxyoctenone, isolated from Streptomyces sp. causes G1cell cycle arrest and induces apoptosis of HeLa cells Cancer Science. ,vol. 98, pp. 795- 802 ,(2007) , 10.1111/J.1349-7006.2007.00473.X
Wilhelm Ansorge, Ingrid Hoffmann, Daniel Mertens, Sybille Wagerer, Rainer Saffrich, Christiane Lammer, The cdc25B phosphatase is essential for the G2/M phase transition in human cells Journal of Cell Science. ,vol. 111, pp. 2445- 2453 ,(1998) , 10.1242/JCS.111.16.2445
R. Elizabeth Grigory, Anni F. Delisa, Paclitaxel: a new antineoplastic agent for refractory ovarian cancer. Clinical pharmacy. ,vol. 12, pp. 401- 415 ,(1993) , 10.1093/AJHP/50.7.1491
Dong Hoon Suh, Kidong Kim, Jae Weon Kim, Major clinical research advances in gynecologic cancer in 2011. Journal of Gynecologic Oncology. ,vol. 23, pp. 53- 64 ,(2012) , 10.3802/JGO.2012.23.1.53
Harald zur Hausen, Human papillomaviruses and their possible role in squamous cell carcinomas. Current Topics in Microbiology and Immunology. ,vol. 78, pp. 1- 30 ,(1977) , 10.1007/978-3-642-66800-5_1
David O. Morgan, David Morgan, The Cell Cycle: Principles of Control ,(2006)
Wendell K, Jordan Ma, Wilson L, Copp H, Gardiner S, Derry Wb, Mitotic Block Induced in HeLa Cells by Low Concentrations of Paclitaxel (Taxol) Results in Abnormal Mitotic Exit and Apoptotic Cell Death Cancer Research. ,vol. 56, pp. 816- 825 ,(1996)
Xuerong Sun, Jian Ge, Ping Ma, Lian Zhou, Yaqin Liu, Qianying Gao, Juan Tan, PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1. Molecular Vision. ,vol. 15, pp. 2683- 2695 ,(2009)
Ichiro Takemasa, Hirofumi Yamamoto, Mitsugu Sekimoto, Masayuki Ohue, Shingo Noura, Yasuhiro Miyake, Takashi Matsumoto, Tomohiko Aihara, Naohiro Tomita, Yasuhiro Tamaki, Isao Sakita, Nobuteru Kikkawa, Nariaki Matsuura, Hitoshi Shiozaki, Morito Monden, None, Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Research. ,vol. 60, pp. 3043- 3050 ,(2000)